Inicio › Enfermedades autoinmunes › Illinois › Chicago
Ensayos clínicos de Enfermedades autoinmunes en Chicago, IL
13 estudios para Enfermedades autoinmunes buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
ReclutandoFase 2/3
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
ReclutandoFase 2
- University of Chicago, Department of Medicine: Rheumatology, Chicago
Study of PTC844 in Participants With Active Rheumatoid Arthritis
ReclutandoFase 2
- Chicago Arthritis and Regenerative Medicine, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
ReclutandoFase 1
- The University of Chicago Medical Center, Chicago
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
ReclutandoFase 1/2
- Northwestern Memorial Hospital, Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
ReclutandoFase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
ReclutandoFase 1/2
- Northwestern University, Chicago
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
ReclutandoFase 1/2
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center - Accepting Adult and Adolescent Patients, Chicago
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
ReclutandoFase 2
- University of Chicago, Chicago
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
ReclutandoFase 1/2
- University of Illinois Hospital & Health Sciences System, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- y 2 más
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
ReclutandoFase 1
- Northwestern University, Chicago
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- University of Chicago Medical Center, Chicago
Más información sobre Enfermedades autoinmunes en MedlinePlus
Ensayos de Enfermedades autoinmunes en otras ciudades
- Houston, TX21 estudios
- Washington, DC19 estudios
- New York City, NY19 estudios
- Philadelphia, PA17 estudios
- Durham, NC15 estudios
- Boston, MA13 estudios
- Los Angeles, CA12 estudios
- Atlanta, GA9 estudios
- Dallas, TX9 estudios
- Miami, FL8 estudios
- Milwaukee, WI8 estudios
- Cleveland, OH8 estudios
Otros estudios en Chicago
- Cáncer de seno59 estudios
- Cáncer de pulmón de células no pequeñas59 estudios
- Cáncer (todos los tipos)51 estudios
- Cáncer de próstata45 estudios
- Cáncer de pulmón43 estudios
- Cáncer metastásico42 estudios
- Obesidad40 estudios
- Cáncer de ovario36 estudios
- Cáncer del colon y del recto32 estudios
- Accidente cerebrovascular31 estudios
- Carcinoma de células escamosas de cabeza y cuello29 estudios
- Sobrepeso29 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.